Clinical Trial Update: The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating whether acetylcysteine can mitigate oxidative stress–related damage in patients undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Atherosclerosis
• End-stage Renal Disease

Drugs mentioned

• Acetylcysteine (Acetylcysteine)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Anemia, Atherosclerosis | Phase 4 | Status: UNKNOWN